CoChat

In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method

Siervo, Mario, Jackson, Sarah J., Bluck, Les J.C. · 2011 · Journal of Hypertension

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Nitric oxide synthesis is declined in cardiovascular and metabolic diseases associated with endothelial dysfunction such as type 2 diabetes, hypertension or congestive heart failure. The objectives were to validate a novel stable isotopic method for the determination of in-vivo nitric oxide synthesis and to evaluate differences in nitric oxide synthesis in obese patients with and without metabolic syndrome (MetSyn). METHODS: The new method, called oral nitrate test (ONT), measured the decay in saliva or urine samples of an oral dose of labelled sodium nitrate. The ONT method was compared to a validated method (frequent sampling arginine test, FSAT method) in 10 healthy adult volunteers (BMI range = 20.8-27.3 kg/m). The accuracy of the saliva ONT method was then tested by measuring nitric oxide synthesis in seven healthy, normal weight individuals, seven obese patients without MetSyn and seven obese patients with MetSyn. RESULTS: The estimated rate of nitric oxide synthesis was 0.63 ± 0.20 μmol/h per kg from the data obtained from saliva, and 0.50 ± 0.14 μmol/h per kg from urine. The agreement of the saliva ONT method with the FSAT method (Δ = +0.02 ± 0.24; P = 0.79) was superior to the urine ONT method (Δ = -0.11 ± 0.20; P = 0.13). Obese patients with MetSyn had a significantly lower nitric oxide production rate (0.21 ± 0.13 μmol/h per kg; P = 0.009) than healthy normal weight individuals (0.63 ± 0.30 μmol/h per kg), whereas nitric oxide production rate was intermediate in obese patients without MetSyn (0.49 ± 0.22 μmol/h per kg; P = 0.33). CONCLUSION: The advantages of the new saliva ONT method are its accuracy, sensitivity and lack of invasiveness, which could make it a reference method for the assessment of in-vivo rates of whole-body nitric oxide synthesis.

Overview

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e3283487806

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Ellger, 2008, Modulation of regional nitric oxide metabolism: blood glucose control or insulin Intensive Care M, ed, 34, 1525

Cited by

See all 44

Metadata

Authors
Siervo, M., Jackson, S. J., & Bluck, L. J. C.
Affiliations
MRC Elsie Widdowson Laboratory (GB)
Corresponding author
Bluck, Les J.C.
Venue
Journal of Hypertension
Published
2011-08
Volume
29
Issue
8
Pages
1515-1527
ISSN
0263-6352 (ISSN-L)
OpenAlex
W1965369215
Cited by
44
References
50
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 2 · 2016: 6 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
1.75
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
nitric oxide production, metabolic syndrome, obesity, stable isotope tracers, endothelial dysfunction
MeSH terms
Adult, Diabetes Mellitus, Type 2, Diagnostic Tests, Routine, Female, Heart Failure, Humans, Hypertension, Isotopes, Male, Middle Aged, Models, Theoretical, Nitrates, Nitric Oxide, Obesity, Saliva, Sensitivity and Specificity, Reproducibility of Results, Comorbidity, Case-Control Studies, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. https://app.cochat.ai/papers/10.1097/hjh.0b013e3283487806
The paper
Siervo, M., Jackson, S. J., & Bluck, L. J. C. (2011). In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e3283487806

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.